Related Experiment Videos
Immunoglobulin and circulating immune complex kinetics during immunoadsorption onto protein A sepharose
N Braun1, S Gutenberger, C M Erley
1Medizinischen Klinik und Poliklinik, Abteilung III, Tübingen, Germany. nbraun@uni-tuebingen.de
Transfusion Science
|February 6, 1998
Summary
Protein A immunoadsorption effectively removes immunoglobulins and autoantibodies from circulation. However, intravenous immunoglobulin administration should be avoided due to binding site competition, impacting therapy efficacy.
Area of Science:
- Biochemistry
- Immunology
- Medical Technology
Background:
- Protein A immunoadsorption is a therapeutic apheresis technique.
- It targets immunoglobulins (IgG), autoantibodies, and circulating immune complexes.
- Understanding the kinetics of immunoglobulin removal is crucial for optimizing treatment.
Purpose of the Study:
- To evaluate the efficacy of protein A immunoadsorption in removing various immune components.
- To determine the in vivo kinetics of IgG subclass elimination and regeneration.
- To assess the impact of co-administered intravenous immunoglobulins on treatment effectiveness.
Main Methods:
- In vivo kinetic studies were conducted.
- Plasma samples were analyzed for immunoglobulin levels.
- Elimination and redistribution half-times for IgG subclasses were calculated.
Main Results:
- Protein A immunoadsorption effectively cleared autoantibodies and immune complexes.
- All IgG subclasses were removed, with variable IgG3 elimination.
- IgG elimination half-times ranged from 2.9 to 4.8 days without immunosuppression.
- IgG redistribution/denovo synthesis half-times were 2.1–8.8 days.
Conclusions:
- Protein A immunoadsorption is effective for removing pathogenic immune molecules.
- Therapeutic strategies must account for IgG elimination kinetics and potential competition with IVIg.
- Careful patient management is needed to avoid interference from intravenous immunoglobulin administration.